CDC recommends Pfizer maternal RSV vaccine to protect infants, paving way for fall availability

[ad_1] A doctor vaccinates an infant against respiratory syncytial virus (RSV) in a treatment room of her paediatric practice. Swen Pförtner | Picture Alliance | Getty Images The Centers for Disease Control and Prevention on Friday recommended Pfizer‘s maternal vaccine that protects infants from respiratory syncytial virus, putting the shot on track to be available in the U.S. this…

Read More

Biden administration unveils first 10 drugs subject to Medicare price negotiations

[ad_1] The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans.  President Joe Biden’s Inflation Reduction Act, which passed in a party-line vote last year, gave Medicare…

Read More

FDA approves Pfizer maternal RSV vaccine for infants

[ad_1] CFOTO | Future Publishing | Getty Images The Food and Drug Administration on Monday approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. Pfizer’s RSV shot is already approved and available in the U.S. for older adults. It’s now the second…

Read More

Infant RSV shot wins backing of CDC advisors, paving way for fall availability

[ad_1] A RSV-infected child receives treatment, as RS-Virus infections spread among children at Missio children’s clinic Moenchberg, in Wuerzburg, Germany, December 2, 2022.  Heiko Becker | Reuters The first shot that protects all infants against respiratory syncytial virus, or RSV, won the unanimous backing of an advisory panel to the Centers for Disease Control and…

Read More